AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25549192 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Blood Pressure (ABP)
Number of subjects: 20
Study 24692475 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (target INR 2-3)
Number of subjects: 973
Study 24692475 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (75 mg/d)
Number of subjects: 973
Study 22179601 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol (group L, n = 32)
Number of subjects: 64
Study 22179601 — intervention group
Group type: COMPARATOR
Intervention: Nontreated (group N, n = 32)
Number of subjects: 64
Study 20437641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cancer screening programme (2007-2008)
Number of subjects: 6000
Study 20437641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cancer screening programme
Number of subjects: 6000
Study 17364234 — intervention group
Group type: EXPERIMENTAL
Intervention: OSI-7904L 12 mg/m2 intravenously every 21 days
Number of subjects: 22
Study 17364234 — intervention group
Group type: COMPARATOR
Intervention: 5-FU/LV (intravenous l-LV 200 mg/m2, bolus 5-FU 400 mg/m2 and a 46-h infusion of 5-FU 2,400 mg/m2) every 14 days
Number of subjects: 22
Study 16291062 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertapenem (1 g daily; n=295)
Number of subjects: 586
Study 12122922 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of ketamine
Number of subjects: 0
Study 12122922 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of a weak opioid and an NMDA-receptor antagonist
Number of subjects: 0
Study 10037348 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-switched Alexandrite (QS Alex) laser
Number of subjects: 33
Study 10037348 — intervention group
Group type: COMPARATOR
Intervention: Q-switched neodymium:yttrium-aluminum-garnet (QS Nd:YAG) laser
Number of subjects: 33
Study 8560901 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg/day (LDL < 195 mg/dl) or 20 mg/day (LDL > 195 mg/dl)
Number of subjects: 64
Study 8560901 — intervention group
Group type: COMPARATOR
Intervention: Bezafibrate 600 mg/day
Number of subjects: 64
Study 8560901 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 64
Study 8560901 — intervention group
Group type: COMPARATOR
Intervention: Bezafibrate
Number of subjects: 64
Study 3389862 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 IU growth hormone three days a week (group 1)
Number of subjects: 42
Study 3389862 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 IU six days a week (group 2)
Number of subjects: 42
Study 3389862 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 IU twice daily six days a week (group 3)
Number of subjects: 42
Study 31407230 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin plus gemcitabine (EG)
Number of subjects: 119
Study 31407230 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel plus gemcitabine (PG)
Number of subjects: 119
Study 31407230 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutation signature 3
Number of subjects: 119
Study 31407230 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutation signature 3 (low vs. high)
Number of subjects: 119
Study 28181206 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (Symfona® forte 120 mg) twice-daily for 6 months
Number of subjects: 50
Study 28181206 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 50
Study 26163170 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette TV advertisements
Number of subjects: 3655
Study 23405025 — intervention group
Group type: EXPERIMENTAL
Intervention: Wristwatch cueing device over the hemiplegic arm for three hours a day, five days per week, for three weeks, plus conventional rehabilitation
Number of subjects: 40
Study 23405025 — intervention group
Group type: COMPARATOR
Intervention: Sham device with the same rehabilitation process
Number of subjects: 40
Study 23405025 — intervention group
Group type: EXPERIMENTAL
Intervention: Wristwatch cueing device
Number of subjects: 40
Study 21381497 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intra-articular injection of hyaluronic acid products
Number of subjects: 2343
Study 18156154 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-based hand motor therapy emphasizing intense active movement repetition, attention, speed, force, precision, and timing, including virtual reality games for 3 weeks.
Number of subjects: 0
Study 18156154 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic assistance in all sessions.
Number of subjects: 0
Study 18156154 — intervention group
Group type: EXPERIMENTAL
Intervention: Grasp task practiced during robotic therapy.
Number of subjects: 0
Study 18156154 — intervention group
Group type: COMPARATOR
Intervention: Non-practiced task, supination/pronation.
Number of subjects: 0
Study 20958896 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing promotion with free soap
Number of subjects: 30
Study 20958896 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing promotion with free waterless hand sanitizer
Number of subjects: 30
Study 20958896 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-intervention)
Number of subjects: 30
Study 17564407 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivated to appear as sleepy as possible during MSLT
Number of subjects: 12
Study 17564407 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivated to be wakeful during MWT
Number of subjects: 12
Study 12243016 — intervention group
Group type: EXPERIMENTAL
Intervention: BPTB allograft (Tutoplast)
Number of subjects: 268
Study 12243016 — intervention group
Group type: COMPARATOR
Intervention: BPTB autograft
Number of subjects: 268
Study 9484356 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID use
Number of subjects: 2651
Study 9484356 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-indigestion drug use
Number of subjects: 2651
Study 8057411 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone (150 mg to 200 mg)
Number of subjects: 35
Study 8057411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 8057411 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 35
Study 3246169 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/kg ceftriaxone (single dose)
Number of subjects: 60
Study 3246169 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/kg ceftriaxone (3 consecutive days)
Number of subjects: 60
Study 11747665 — intervention group
Group type: EXPERIMENTAL
Intervention: Telegenetic consultation via videoconferencing
Number of subjects: 33
Study 11747665 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face conventional clinic (control)
Number of subjects: 33
Study 31354153 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique (asymmetric sinus excision with additional skin excision)
Number of subjects: 100
Study 31354153 — intervention group
Group type: COMPARATOR
Intervention: Standard Karydakis technique
Number of subjects: 100
Study 31354153 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 29504676 — intervention group
Group type: EXPERIMENTAL
Intervention: Semielevated side‐lying (ESL) position
Number of subjects: 80
Study 29504676 — intervention group
Group type: COMPARATOR
Intervention: Semielevated supine (ESU) position
Number of subjects: 80
Study 27384040 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) combined with conventional scaling and root planing (SRP)
Number of subjects: 13
Study 27384040 — intervention group
Group type: COMPARATOR
Intervention: Conventional scaling and root planing (SRP) alone
Number of subjects: 13
Study 25206313 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal orifice-covered (TOC) group
Number of subjects: 66
Study 25206313 — intervention group
Group type: COMPARATOR
Intervention: Tracheal orifice-exposed (TOE) group
Number of subjects: 66
Study 22222052 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN α-2a (180 μg once weekly) + weight-based RBV
Number of subjects: 20
Study 22222052 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN α-2b (1.5 μg/kg once weekly) + weight-based RBV
Number of subjects: 20
Study 22222052 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (Tac)
Number of subjects: 20
Study 22222052 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 20
Study 20061999 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 282
Study 20061999 — intervention group
Group type: COMPARATOR
Intervention: Control (CNI-based immunosuppression)
Number of subjects: 282
Study 17379017 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (15 mg/d)
Number of subjects: 39
Study 17379017 — intervention group
Group type: COMPARATOR
Intervention: Voglibose (0.6 mg/d)
Number of subjects: 39
Study 15308513 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 222
Study 15308513 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 1000 mg
Number of subjects: 222
Study 11136283 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg daily
Number of subjects: 16
Study 11136283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9851955 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab plus low-dose heparin
Number of subjects: 200
Study 9851955 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose heparin
Number of subjects: 200
Study 7988579 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 80
Study 7988579 — intervention group
Group type: COMPARATOR
Intervention: Methohexitone
Number of subjects: 80
Study 3056085 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibraccel (50-ml infusions lasting 30 min each, started immediately after antagonism by protamine chloride, followed by subsequent 50-ml infusions every 4 h until 20 h after extracorporeal circulation)
Number of subjects: 40
Study 3056085 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusions at corresponding times
Number of subjects: 40
Study 30168511 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physiotherapy including treatment in the spa capsule (n=29)
Number of subjects: 86
Study 30168511 — intervention group
Group type: COMPARATOR
Intervention: Local vacuum therapy (n=28)
Number of subjects: 86
Study 30168511 — intervention group
Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation therapy (n=29)
Number of subjects: 86
Study 28619175 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate 4.5g
Number of subjects: 116
Study 28619175 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate 6g
Number of subjects: 116
Study 28619175 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate 9g
Number of subjects: 116
Study 28619175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 25877694 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive direct anterior approach
Number of subjects: 163
Study 25877694 — intervention group
Group type: COMPARATOR
Intervention: Direct lateral approach
Number of subjects: 163
Study 22879452 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group (received video and GPS feedback)
Number of subjects: 54
Study 22879452 — intervention group
Group type: COMPARATOR
Intervention: Education group (classroom-based course)
Number of subjects: 54
Study 22879452 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional intervention)
Number of subjects: 54
Study 21946134 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined microcurrent reflexotherapy (MCRT) and cortexin
Number of subjects: 78
Study 21946134 — intervention group
Group type: COMPARATOR
Intervention: Microcurrent reflexotherapy (MCRT) only
Number of subjects: 78
Study 18710330 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorative yoga intervention (15 sessions of 90 minutes each over 10 weeks)
Number of subjects: 26
Study 18710330 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 26
Study 16536957 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate antibiotics
Number of subjects: 315
Study 16536957 — intervention group
Group type: COMPARATOR
Intervention: Delayed prescribing (at parents' discretion)
Number of subjects: 315
Study 16536957 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior episodes of AOM
Number of subjects: 315
Study 14574032 — intervention group
Group type: EXPERIMENTAL
Intervention: Implanted defibrillators
Number of subjects: 4
Study 14574032 — intervention group
Group type: COMPARATOR
Intervention: Pharmacologic antiarrhythmic therapy
Number of subjects: 4
Study 10225168 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1.5 mg kg‐1
Number of subjects: 61
Study 10225168 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 1.5 micrograms kg‐1
Number of subjects: 61
Study 8903382 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (1 mg/d, 5 days per week) + UDCA (13-15 mg x kg(‐1) x day(‐1))
Number of subjects: 74
Study 8903382 — intervention group
Group type: COMPARATOR
Intervention: UDCA alone (placebo)
Number of subjects: 74
Study 1864448 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg/day diclofenac potassium for 7 days
Number of subjects: 60
Study 1864448 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 g/day ibuprofen
Number of subjects: 60
Study 1864448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 6350471 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir
Number of subjects: 59
Study 6350471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 30472141 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intranasal stimulation
Number of subjects: 145
Study 30472141 — intervention group
Group type: EXPERIMENTAL
Intervention: ITN stimulation
Number of subjects: 145
Study 30472141 — intervention group
Group type: COMPARATOR
Intervention: Extranasal stimulation (active control)
Number of subjects: 145
Study 30472141 — intervention group
Group type: COMPARATOR
Intervention: Sham intranasal stimulation (inactive control)
Number of subjects: 145
Study 27797421 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic cleansing brush (normal speed)
Number of subjects: 20
Study 27797421 — intervention group
Group type: COMPARATOR
Intervention: Manual cleansing
Number of subjects: 20
Study 27083135 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% dextrose in Ringer lactate (RL) at 10 ml·kg(‐1) ·h(‐1) (Group D1)
Number of subjects: 45
Study 27083135 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% dextrose in Ringer lactate (RL) at 10 ml·kg(‐1) ·h(‐1) (Group D2)
Number of subjects: 45
Study 27083135 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% dextrose in N/5 saline at 4 ml·kg(‐1) ·h(‐1) and replacement fluid with 6 ml·kg(‐1) ·h(‐1) of RL (Group D4)
Number of subjects: 45
Study 25096822 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose solution (25 g)
Number of subjects: 121
Study 25096822 — intervention group
Group type: COMPARATOR
Intervention: Saccharose placebo
Number of subjects: 121
Study 25096822 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose intolerance defined as SS ≥ 6 points after subtracting placebo effect
Number of subjects: 121
Study 22621727 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Training (PT)
Number of subjects: 62
Study 22621727 — intervention group
Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 62
Study 19246722 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole + Midazolam on Day 5
Number of subjects: 0
Study 19246722 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole + Midazolam on Day 2
Number of subjects: 0
Study 17617338 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical pathway implementation
Number of subjects: 90
Study 17617338 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardization of surgical techniques
Number of subjects: 90
Study 17617338 — intervention group
Group type: COMPARATOR
Intervention: Single vendor implant selection
Number of subjects: 90
Study 15222511 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral micronized progesterone
Number of subjects: 60
Study 15222511 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal micronized progesterone
Number of subjects: 60
Study 12460330 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF‐I levels in younger age group (20-44)
Number of subjects: 288
Study 12460330 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF‐I levels in middle age group (45-59)
Number of subjects: 288
Study 12460330 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF‐I levels in older age group (over 59 years)
Number of subjects: 288
Study 10403710 — intervention group
Group type: EXPERIMENTAL
Intervention: Careful scrutiny of items at retrieval
Number of subjects: 0
Study 10403710 — intervention group
Group type: EXPERIMENTAL
Intervention: Noticing specific differentiating perceptual features of the objects during encoding
Number of subjects: 0
Study 10403710 — intervention group
Group type: EXPERIMENTAL
Intervention: Encouraged to use more stringent decision criteria
Number of subjects: 0
Study 10403710 — intervention group
Group type: EXPERIMENTAL
Intervention: Both manipulations (careful scrutiny and noticing features)
Number of subjects: 0
Study 7591555 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual laser ablation of the prostate (VLAP)
Number of subjects: 0
Study 7591555 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection (TURP)
Number of subjects: 0
Study 2174320 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion during euglycemia
Number of subjects: 7
Study 2174320 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion during hyperglycaemia
Number of subjects: 7
Study 2174320 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid infusion during hyperinsulinaemia with euglycemia or hyperglycaemia
Number of subjects: 7
Study 7239110 — intervention group
Group type: EXPERIMENTAL
Intervention: Starch enemas (10%; 1000 ml t.i.d.) plus neomycin tablets
Number of subjects: 18
Study 7239110 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose enemas (20%; 1000 ml t.i.d.) plus placebo tablets
Number of subjects: 18
Study 7239110 — intervention group
Group type: COMPARATOR
Intervention: Control group (starch enemas plus neomycin tablets)
Number of subjects: 18
Study 7239110 — intervention group
Group type: COMPARATOR
Intervention: Control group (lactose enemas plus placebo tablets)
Number of subjects: 18
Study 30709694 — intervention group
Group type: EXPERIMENTAL
Intervention: LED light irradiation from initial clinical assessment (T0) until the completion of scaling and root planning (T1) (LED01)
Number of subjects: 19
Study 30709694 — intervention group
Group type: EXPERIMENTAL
Intervention: LED light irradiation from T1 until re-evaluation (T2) (LED02)
Number of subjects: 19
Study 30709694 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (no LED light irradiation)
Number of subjects: 19
Study 30709694 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 19
Study 29565642 — intervention group
Group type: EXPERIMENTAL
Intervention: MACI (Matrix‐Applied Characterized Autologous Cultured Chondrocytes)
Number of subjects: 144
Study 29565642 — intervention group
Group type: COMPARATOR
Intervention: Microfracture
Number of subjects: 144
Study 29565642 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI evaluation for both treatments
Number of subjects: 144
Study 27537995 — intervention group
Group type: EXPERIMENTAL
Intervention: Cal/BD aerosol foam
Number of subjects: 1104
Study 27537995 — intervention group
Group type: COMPARATOR
Intervention: Cal/BD ointment
Number of subjects: 1104
Study 27537995 — intervention group
Group type: COMPARATOR
Intervention: BD aerosol foam
Number of subjects: 1104
Study 27537995 — intervention group
Group type: COMPARATOR
Intervention: Cal aerosol foam
Number of subjects: 1104
Study 27537995 — intervention group
Group type: COMPARATOR
Intervention: Aerosol foam vehicle
Number of subjects: 1104
Study 27537995 — intervention group
Group type: COMPARATOR
Intervention: Ointment vehicle
Number of subjects: 1104
Study 24595800 — intervention group
Group type: EXPERIMENTAL
Intervention: MarginProbe device
Number of subjects: 596
Study 24595800 — intervention group
Group type: COMPARATOR
Intervention: Control (standard intraoperative methods for margin assessment)
Number of subjects: 596
Study 22791622 — intervention group
Group type: EXPERIMENTAL
Intervention: Wingate test at 07:00-h
Number of subjects: 15
Study 22791622 — intervention group
Group type: EXPERIMENTAL
Intervention: Wingate test at 17:00-h
Number of subjects: 15
Study 20517667 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotics
Number of subjects: 68
Study 20517667 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotics and heat-deactivated probiotics
Number of subjects: 68
Study 20517667 — intervention group
Group type: COMPARATOR
Intervention: Mechanical bowel cleaning
Number of subjects: 68
Study 18773730 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessments of body shape attractiveness across seasons
Number of subjects: 114
Study 18773730 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessments of breast attractiveness across seasons
Number of subjects: 114
Study 18773730 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessments of face attractiveness across seasons
Number of subjects: 114
Study 15749734 — intervention group
Group type: EXPERIMENTAL
Intervention: A-line AEP Monitor at AAI 10
Number of subjects: 108
Study 15749734 — intervention group
Group type: EXPERIMENTAL
Intervention: End-expiratory sevoflurane concentration
Number of subjects: 108
Study 15749734 — intervention group
Group type: EXPERIMENTAL
Intervention: A-line AEP Monitor
Number of subjects: 108
Study 15749734 — intervention group
Group type: EXPERIMENTAL
Intervention: AAI for 90% probability of acceptable intubation conditions
Number of subjects: 108
Study 14508821 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmastectomy radiotherapy (NSABP B-04)
Number of subjects: 3515
Study 14508821 — intervention group
Group type: COMPARATOR
Intervention: No radiotherapy (NSABP B-04)
Number of subjects: 3515
Study 14508821 — intervention group
Group type: EXPERIMENTAL
Intervention: Postlumpectomy breast irradiation (NSABP B-06)
Number of subjects: 3515
Study 14508821 — intervention group
Group type: COMPARATOR
Intervention: Total mastectomy or lumpectomy without radiotherapy (NSABP B-06)
Number of subjects: 3515
Study 11304721 — intervention group
Group type: EXPERIMENTAL
Intervention: 220 mg of naproxen sodium
Number of subjects: 30